Lauxera Capital Partners is proud to announce its investment in Antaros, a leading Swedish Imaging Drug Development Partner Antaros MedicalFund II Lauxera Capital Partners is proud to announce its investment in Antaros, a leading Swedish Imaging Drug Development Partner
Lauxera Invests €50m in Acandis, a German, Neurovascular Medical Device Company Dedicated to the Prevention and Treatment of Stroke Fund IIAcandis Lauxera Invests €50m in Acandis, a German, Neurovascular Medical Device Company Dedicated to the Prevention and Treatment of Stroke
